tradingkey.logo

Krystal Biotech Granted FDA Meeting For KB707 For October

ReutersAug 21, 2025 4:43 PM

- Krystal Biotech Inc KRYS.O:

  • KRYSTAL BIOTECH ANNOUNCES UPDATE ON DEVELOPMENT PLANS FOR ONCOLOGY PROGRAM KB707 AND PRIORITIZATION OF INHALED KB707 FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER

  • KRYSTAL BIOTECH INC - GRANTED FDA MEETING FOR KB707 FOR OCTOBER

  • KRYSTAL BIOTECH INC - INHALED KB707 SAFE, NO GRADE 4 OR 5 ADVERSE EVENTS

  • KRYSTAL BIOTECH INC - PAUSES ENROLLMENT IN OPAL-1 STUDY

  • KRYSTAL BIOTECH INC - ENROLLMENT CONTINUES IN KYANITE-1 STUDY FOR INHALED KB707

  • KRYSTAL BIOTECH INC: CO MAY ADJUST DEVELOPMENT PLANS FOR INTRATUMORAL KB707

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI